Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: …
WEB2 days ago · In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $18.95, with a -1.86% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%.
Hims & Hers announces access to compounded GLP-1 injections …
WEBSep 18, 2024 · Hims & Hers is introducing the Service Appreciation Initiative to give eligible U.S. military, veterans, teachers, nurses and first responders the ability to benefit from compounded semaglutide GLP-1s at significantly lower costs.
Hims & Hers Newsroom
WEBKristen Bell Partners with Hers as its First Mental Health Ambassador. January 12, 2023. Read the latest news from Hims & Hers.
Hims & Hers Health, Inc. (HIMS) Latest Stock News & Headlines …
WEBGet the latest Hims & Hers Health, Inc. (HIMS) stock news and headlines to help you in your trading and investing decisions.
Hims & Hers Is Now Selling Semaglutide: Here's What You …
WEBMay 22, 2024 · Telehealth prescription company Hims & Hers has a new semaglutide initiative. The program will offer compounded semaglutide to customers starting from $199 a month. The company also plans to sell branded Wegovy and Ozempic when it is available.
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial …
WEBMay 6, 2024 · SAN FRANCISCO-- (BUSINESS WIRE)-- Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2024 in a shareholder letter that is posted at investors.hims.com.
Hims & Hers weight loss adds compounded GLP-1 injections
WEBMay 20, 2024 · Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections. The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced...
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year …
WEBFeb 26, 2024 · HIMS. Revenue of $872.0 million, up 65% year-over-year in 2023. Net income of $1.2 million; Adjusted EBITDA profitability of $20.6 million in Q4 2023. Subscribers grew to 1.5 million, up 48%...
Affordability and Safety: How Hims & Hers is Delivering a New …
WEBMay 20, 2024 · Starting today, Hims & Hers is providing access to compounded GLP-1 treatments for eligible customers at prices starting at $199/monthly.
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly
WEB11 hours ago · Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's popular weight-loss drugs are no longer on its list of drugs in short supply. The FDA ...